YAYINLAR VE MAKALELER

Uluslar arası Makaleler

 

35 – Ozmen OA, Tüzemen G, Kasapoğlu F, Ozmen S, Coşkun H, Ursavaş A, Karadağ M, Onart S.; The reliability of SleepStrip as a screening test in obstructive sleep apnea syndrome. Kulak Burun Bogaz Ihtis Derg. 2011 Jan-Feb;21(1):15-9.

34 – Ursavas A, Ozarda Ilcol Y, Nalci N, Karadag M, and Ege E ; Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: Role of obesity.  Ann Thorac Med. 2010 Jul;5(3):161-5.

 

33 -Vatansever E, Surmen-Gur E, Ursavas A, Karadag M.; Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath. 2010 Jun 20. [Epub ahead of print]

 

32 – Yakut T, Karkucak M, Ursavas A, Gulten T, Burgazlioglu B, Gorukmez O, Karadag M.: Lack of association of ACE gene I/D polymorphism with obstructive sleep apnea syndrome in Turkish patients. Genet Mol Res 2010 Apr 20;9(2):734-8.

 

31– Coşkun F, Ege E, Uzaslan E, Ediger D, Karadağ M, Gözü O: Evaluation of thyroid hormone levels and somatomedin-C (IGF-1) in patients with chronic obstructive pulmonary disease (COPD) and relation with the severity of the disease. Tuberk Toraks. 2009;57(4):369-75.

30- Ursavaş A, Karadağ M, Uzaslan E, Yesilkaya S,Coskun F, Ege E. Prognostic Significance of Plasma D-Dimer Levels in Patients with Lung Cancer, Eur J G Med 09.11.2009 (Baskıda)

29– Ursavaş A, Karadağ M: Sleep breathing disorders in pregnancy. Tuberk Toraks. 2009;57(2):237-43.

 

28- Ozturk A; Sarihan S; Ercan I; Karadag M: Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy. Am J Clin Oncol 32(1)February 2009pp 65-72

27– Ursavaş A, Ercan I, Arabaci R, Sekir U, Ozkaya G, Demirdögen E, Karadag M, Gozu RO, “The association between snoring, daytime sleepiness, and obesity in professional wrestlers”, Eur J Gen Med 2008; 5: 9-15

affiliazione_autori – ignora

26– Cecener G,Tunca B, Egeli U, Karadag M, Vatan O, Uzaslan E, Tolunay S; Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer. Tumori, 94: 845-848, 2008

25– Ursavaş A, Karadag M, Oral AY, Demirdogen E, Oral HB, Ege E.:Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med. 102:8: 1193-1197   2008

24-Ursavas A, Karadag M, Gullulu M, Demirdogen E, Coskun F, Onart S, Gozu RO.:   Low-grade urinary albumin excretion in normotensive/non-diabetic obstructive sleep apnea patients. Sleep Breath 2008 Aug;12(3):217-22

 

23 – Sağlam DA, Ursavaş A, Karadağ M, Yilmaztepe Oral A, Coşkun F, Gözü RO .: The evaluation to relationship between serum vascular endothelial growth factor (VEGF) level, metastases and other tumor markers in patients with lung cancer. Tuberk Toraks. 2008;56(1):50-5

 

22– Yavuz Z, Ursavaş A, Ege E, Ozarda Ilçol Y, Karadağ M, Uzaslan E, Gözü RO.: Homocysteine levels in patients with obstructive sleep apnea syndrome.: Tuberk Toraks. 2008;56(1):37-42.

 

21- Ursavaş A, Karadağ M, Burgazlıoğlu B, Coşkun F, Ceylan E, Onart S, Gözü RO : Relief from Sleep Apnea After Radiation and Chemotherapy. Clinical Lung Clinical Lung Cancer, Vol. 8, No. 8, 502-503, 2007

 

20- Ursavaş A, Karadağ M, Nalcı N, Ercan İ, Gözü RO:Self-Reported Snoring, Maternal Obesity and Neck Circumference as Risk Factors for Pregnancy-Induced Hypertension and Preeclampsia. Respiration 2008;76:33-39

 

19- Ursavaş A, Karadag M, Ercan I, Özkubat Ö, Yeşilkaya S, Coskun F, Gözü RO. Serum Carcınoembryonıc Antıgen Level As A Predıctıve Marker For Dıstant Metastasıs In Non-Small Cell Lung Cancer. Eur J G Med 2007; 4: 107-14

 

18 – Ursavaş A, Karadağ M, İlcol YÖ, Ercan İ, Burgazlıoğlu B, Coşkun F, Gözü RO : Low Level of IGF-1 in Obesity May Be Related to Obst ructive Sleep Apnea Syndrome. Lung. 2007 185.309-314

 

17 –  YİLMAZTEPE  A.,ULUKAYA  E.,ZİK B., YAGCİ A.,SEVİMLİ A., YİLMAZ M., BAHADİR E. B, KOC M., AKGOZ S., KARADAG M., TOKULLUGİL  A; Soluble Vascular Endothelial Growth Factor Receptor-1 (sVEGFR-1) is Decreased in Lung Cancer Patients Showing Progression: A Pilot Study.  Cancer Invst 2007 Aug;25(5):322-7.

 

16– URSAVAS A, KARADAG  M, OZARDA ILCOL Y,BURGAZLİOGLU B, ERCAN İ AND GOZU RO,; Relationship Between Serum Substance P Levels and Daytime Sleepiness in Obstructive Sleep Apnea Syndrome. Chest. 2007; 131:1400-1405

 

15- URSAVAS A, KARADAG M, UZASLAN E, RODOPLU E, DEMİRDOGEN E, BURGAZLİOGLU B, GOZU R O.: Can clinical factors be determinants of bone metastases in non-small cell lung cancer ? Annals of Thoracic Medicine 2007, 2.(1);9-13

 

14- ULUKAYA E, YIMAZTEPE A, AKGÖZ S, LINDER S, KARADAĞ M: The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival. Lung Cancer. 2007 June; 56(3); 399-404

 

13-UrsavaŞ A, KaradaĞ M, Rodoplu E, YIlmaztepe A, Oral B,  Gözü RO. Circulating ICAM-1 and VCAM-1 Levels in Patients with Obstructive Sleep Apnea Syndrome Respiration 2007;74:525-532

 

12-UNCU Y. IRGİL E, KARADAG M, Smoking Patterns among Primary School Students in Turkey. ScientificWorldJournal. 2006 Dec 28;6:1667-73.

 

11-EDİGER D, COŞKUN F, KUNT UZASLAN E, GÜRDAL YÜKSEL E, KARADAĞ M, EGE E, GÖZÜ RO. Clinical effectiveness of nebulised budesonide in the treatment of acute asthma attacks. Tuberk Toraks. 2006;54(2):128-36

 

10-ÇOLAKOĞULLARI M, ULUKAYA E, YILMAZTEPE A, OCAKOĞLU G, YILMAZ M, KARADAĞ M, TOKULLUGİL A. Higher serum nitrate levels are associated wıth poor survival in lung cancer patients. Clin Biochem. 2006 Sep;39(9):898-903

 

9-KOÇ M, EDİGER D, BUDAK F, KARADAĞ M, ORAL HB, UZASLAN E, EGE E, GÖZÜ RO. Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer. Tumori. 2006 Mar-Apr;92(2):149-54

 

8-ERDOĞAN B, UZASLAN E, BUDAK F, KARADAĞ M, EDİGER D, ORAL B, GÖRAL G, EGE E, GÖZÜ O:  The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients. Tuberk Toraks. 2005;53(2):127-31.

 

7- UZASLAN E, URSAVAŞ A, EDİGER D, KARADAĞ M, : An unusual way of tracheal stoma cleaning could end up with foreign body aspiration in a laryngectomized patient. Tuberk Toraks. 2005;53(1):62-5.

 

6– COŞKUN H, KARADAĞ M, ŞENKAYA I, BASUT O.: Removal of an Aspirated Denture Through a Tracheostome. Journal of Bronchology 10: 129-132, 2003

5-Turkish Thoracic Society, Lung and Pleural Malignancies Study Group (AKKOCLU A, ATİKCAN S, AYSAN T, BAYİZ H, CELİK M, CELİK P, CETİNKAYA E, CİKRİKCİOGLU S, CİLDAG O, DUDURGALİ R, GOKSEL T, GONULLU U, GORGUNER M, GUCLU S, GULHAN M, HALİLCOLAR H, HASTURK S, ISİK R, ITİL O, KARADAG M, KAYA A, KİYİK M, KURT B, KURUTEPE M, ONDE G, ORTAKOYLU G, OZAYDİN N, OZSOZ A, OZKURT S, OZTURK C, PELİT A, PERİM K, TASBAKAN S, ULGAN M, UNSAL M, YAVASOGLU G, YİLMAZ U, YUKSEL M). Pattern of Lung Cancer in Turkey, 1994-1998. Respiration 69: 207-210, 2002

4-KARADAĞ M, TUNCA B, ÇEÇENER G, EGELİ Ü, ÖZYARDIMCI N, EGE E, GÖZÜ O: Chromosomal fragile sites and relationship between genetic predisposition to small cell lung cancer: Teratogenesis, Carcinogenesis and Mutagenesis 22:31-40, 2002

 

3-KUNT UZASLAN E, ÖZYARDIMCI N, KARADAĞ M, GÜRDAL YÜKSEL E, GÖZÜ R.O, EGE E: The physician’s intervention in smoking cessation: Results of the five years of smoking cessation clinic. Ann Med Sci 2000; 9: 63-69

 

2-EGELİ Ü., KARADAĞ M., TUNCA B., ÖZYARDIMCI N.: The Expression of Common Fragile Site and Genetic Predisposition to Squamous Cell Lung Cancer. Cancer Genet Cytogenet ; 95:153-158, 1997

 

1- GÜRDAL YÜKSEL E., KARADAĞ M., ÖZYARDIMCI N., KUNT UZASLAN A.E., YARKIN T.: The Role of Cigarette Smoking and Diet on Development of Lung  Cancer. Journal of Environmental Pathology ,Toxicology and Oncology ; 15(2-4): 161-167, 1996

 .

Bir Cevap Yazın

Tasarım: #drriza.com